Eqis Capital Management, Inc. Laboratory Corp Of America Holdings Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$209.01 - $232.56 $51,834 - $57,674	248 Added 15.86%	1,812 $395,000
Q4 2023 Feb 14, 2024	SELL	$197.69 - $227.29 $1,976 - $2,272	-10 Reduced 0.64%	1,564 $355,000
Q3 2023 Nov 13, 2023	SELL	$201.05 - $221.7 $196,425 - $216,600	-977 Reduced 38.3%	1,574 $316,000
Q2 2023 Aug 14, 2023	SELL	$211.93 - $241.33 $61,883 - $70,468	-292 Reduced 10.27%	2,551 $615,000
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $110,499 - $133,555	-518 Reduced 15.41%	2,843 $652,000
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $14,871 - $18,174	73 Added 2.22%	3,361 $791,000
Q3 2022 Oct 24, 2022	BUY	$204.81 - $262.19 $42,190 - $54,011	206 Added 6.68%	3,288 $673,000
Q2 2022 Aug 08, 2022	SELL	$213.86 - $277.87 $120,617 - $156,718	-564 Reduced 15.47%	3,082 $722,000
Q1 2022 May 16, 2022	BUY	$259.82 - $298.18 $129,130 - $148,195	497 Added 15.78%	3,646 $961,000
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $47,258 - $54,672	-174 Reduced 5.24%	3,149 $989,000
Q3 2021 Nov 12, 2021	BUY	$274.82 - $308.34 $7,969 - $8,941	29 Added 0.88%	3,323 $935,000
Q2 2021 Aug 12, 2021	BUY	$251.87 - $278.14 $173,034 - $191,082	687 Added 26.35%	3,294 $909,000
Q1 2021 May 14, 2021	SELL	$204.88 - $255.03 $297,485 - $370,303	-1,452 Reduced 35.77%	2,607 $665,000
Q4 2020 Feb 11, 2021	BUY	$186.91 - $214.42 $558,860 - $641,115	2,990 Added 279.7%	4,059 $826,000
Q3 2020 Nov 10, 2020	BUY	$167.03 - $201.3 $178,555 - $215,189	1,069 New	1,069 $201,000
Q4 2019 Jan 24, 2020	SELL	$163.48 - $173.61 $1.93 Million - $2.05 Million	-11,800 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$159.77 - $178.1 $113,436 - $126,451	-710 Reduced 5.68%	11,800 $1.98 Million
Q2 2019 Jul 18, 2019	BUY	$144.16 - $172.9 $103,362 - $123,969	717 Added 6.08%	12,510 $2.16 Million
Q1 2019 Apr 18, 2019	BUY	$123.7 - $156.3 $361,080 - $456,239	2,919 Added 32.89%	11,793 $1.8 Million
Q4 2018 Jan 25, 2019	SELL	$120.82 - $174.09 $664,268 - $957,146	-5,498 Reduced 38.25%	8,874 $1.12 Million
Q3 2018 Oct 17, 2018	SELL	$167.67 - $188.27 $569,910 - $639,929	-3,399 Reduced 19.13%	14,372 $2.43 Million
Q2 2018 Jul 27, 2018	BUY	$160.33 - $189.41 $241,456 - $285,251	1,506 Added 9.26%	17,771 $3.19 Million
Q1 2018 Apr 06, 2018	BUY	$161.53 - $178.11 $524,649 - $578,501	3,248 Added 24.95%	16,265 $2.63 Million
Q4 2017 Jan 25, 2018	BUY	$147.99 - $163.95 $219,469 - $243,137	1,483 Added 12.86%	13,017 $2.08 Million
Q3 2017 Oct 03, 2017	BUY	$149.47 - $160.56 $1.72 Million - $1.85 Million	11,534	11,534 $1.74 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account